Egetis Therapeutics AB (publ) (OM:EGTX) Commented on Market Rumors. Egetis Has Ongoing Discussions with Certain External Parties Regarding A Potential Acquisition of Company. There Can Be No Certainty That A Public Take-Over Offer Will Be Made, Nor as to Terms of Any Such Offer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 SEK | +3.09% | +11.64% | +25.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.45% | 186M | |
+9.44% | 114B | |
+11.55% | 104B | |
-13.93% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.03% | 17.89B | |
+7.03% | 14.28B | |
+35.48% | 12.55B |
- Stock Market
- Equities
- EGTX Stock
- News Egetis Therapeutics AB
- Egetis Comments on M&A Rumors